On 9 February 2012, orphan designation (EU/3/12/956) was granted by the European Commission to PinCell s.r.l., Italy, for human monoclonal antibody against Fas ligand for the treatment of pemphigus.

The sponsor’s address was updated in May 2020.

Key facts

Active substance
Human monoclonal antibody against Fas ligand
Disease / condition
Treatment of pemphigus
Date of first decision
EU designation number

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

PinCell S.r.l.
Via Vincenzo Gioberti 8
20123 Milan

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating